PlainRecalls
FDA Drug Moderate Class II Terminated

glipiZIDE Extended-Release Tablets, 5 mg, 1000 count bottles, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV --- NDC 0378-0342-10

Reported: March 8, 2017 Initiated: January 19, 2017 #D-0491-2017

Product Description

glipiZIDE Extended-Release Tablets, 5 mg, 1000 count bottles, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV --- NDC 0378-0342-10

Reason for Recall

Presence of Foreign Tablets/Capsules; bottles of Glipizide 5 mg tablets may contain Glipizide 10 mg tablets

Details

Units Affected
1338 bottles
Distribution
Nationwide
Location
Morgantown, WV

Frequently Asked Questions

What product was recalled?
glipiZIDE Extended-Release Tablets, 5 mg, 1000 count bottles, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV --- NDC 0378-0342-10. Recalled by Mylan Pharmaceuticals Inc.. Units affected: 1338 bottles.
Why was this product recalled?
Presence of Foreign Tablets/Capsules; bottles of Glipizide 5 mg tablets may contain Glipizide 10 mg tablets
Which agency issued this recall?
This recall was issued by the FDA Drug on March 8, 2017. Severity: Moderate. Recall number: D-0491-2017.